CLINICAL_TRIALS
trial_result
· 2011-09-07
Clinical Trial Update: Discontinuation Study of the Durability of Effect of Milnacipran for the Treatment of Fibromyalgia [Phase 4]
Summary
A Phase 4 discontinuation study evaluated the durability of milnacipran's effects in fibromyalgia, with results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Forest Laboratories | Conditions: Fibromyalgia | Phase 4 | Status: COMPLETED | Results posted: 2011-09-07